Implementation of an Enhanced Recovery After Surgery Protocol for Cleft Palate Repair.
| Autor: | Hopper SJ; From the University of Mississippi Medical Center, Jackson, MS., Fernstrum CJ, Phillips JB, Sink MC, Goza SD, Brown MI, Brown KW, Humphries LS, Hoppe IC |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Annals of plastic surgery [Ann Plast Surg] 2024 Jun 01; Vol. 92 (6S Suppl 4), pp. S401-S403. |
| DOI: | 10.1097/SAP.0000000000003951 |
| Abstrakt: | Objective: This study examines an Enhanced Recovery After Surgery (ERAS) protocol for patients with cleft palate and hypothesizes that patients who followed the protocol would have decreased hospital length of stay and decreased narcotic usage than those who did not. Design: Retrospective cohort study. Setting: The study takes place at a single tertiary children's hospital. Patients: All patients who underwent cleft palate repair during a 10-year period (n = 242). Interventions: All patients underwent cleft palate repair with the most recent cohort following a new ERAS protocol. Main Outcome Measures: Primary outcomes included hospital length of stay and narcotic usage in the first 24 hours after surgery. Results: Use of local bupivacaine during surgery was associated with decreased initial 24-hour morphine equivalent usage: 2.25 vs 3.38 mg morphine equivalent (MME) (P < 0.01), and a decreased hospital length of stay: 1.71 days vs 2.27 days (P < 0.01). The highest 24-hour morphine equivalent a patient consumed prior to the ERAS protocol implementation was 24.53 MME, compared with 6.3 MME after implementation. Utilization of the ERAS protocol was found to be associated with a decreased hospital length of stay: 1.67 vs 2.18 days (P < 0.01). Conclusions: Use of the proposed ERAS protocol may lead to lower narcotic usage and decreased length of stay. Competing Interests: Conflicts of interest and sources of funding: none declared. (Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|